مجموعة اللوائح العالمية
تصفح 15,090 لائحة من 36 جهة تنظيمية
2,998 تم تحديثها في آخر 30 يومًا. مجموعة عامة — لا حاجة إلى تسجيل للقراءة.
عرض 101–127 من أصل 127 لائحة
Quality Management System Regulation
21 CFR Part 820 establishes Current Good Manufacturing Practice (CGMP) requirements for the design, manufacture, packaging, labeling, storage, installation, and servicing of finished medical devices intended for human use. Manufacturers must establish and maintain a quality management system appropriate for their specific devices. The regulation applies to devices manufactured in the US or imported into the US, and covers manufacturers performing functions such as contract sterilization, relabeling, remanufacturing, and repacking. Blood components and certain other exempted products are excluded.
Human Cells, Tissues, and Cellular and Tissue-Based Products
21 CFR Part 1271 establishes FDA requirements for establishments manufacturing human cells, tissues, and cellular and tissue-based products (HCT/Ps). The regulation creates an electronic registration and listing system and mandates compliance with donor-eligibility procedures, current good tissue practice standards, and communicable disease prevention measures. It applies to HCT/P manufacturers regulated under the Public Health Service Act, whether or not products enter interstate commerce, and requires adherence to manufacturing and quality standards.
Procedures for Performance Standards Development
21 CFR Part 861 establishes procedures for FDA development of performance standards for Class II and Class III medical devices. Standards address device performance characteristics, design, manufacturing processes, quality control, testing requirements, labeling, and distribution restrictions to ensure safety and effectiveness. The FDA coordinates with other federal agencies and stakeholder organizations in standard-setting.
Notification of Defects or Failure to Comply
21 CFR Part 1003 establishes notification requirements for manufacturers of electronic products regarding defects or non-compliance with Federal standards, particularly those involving unintended or excessive electronic product radiation emissions that pose injury risk. Manufacturers must immediately notify the Secretary and relevant dealers, distributors, and purchasers upon discovery of defects or compliance failures in products manufactured after October 1968.
Additional Standards for Miscellaneous Products
21 CFR Part 680 establishes standards for allergenic products used in diagnosis, prevention, or treatment of allergies. Requirements cover source material purity (max 1% foreign material), mold culture processing with approved standard operating procedures, and animal sourcing with veterinary oversight. Manufacturers must document mold identity, processing steps, contamination limits, and report specified animal diseases to the Center for Biologics Evaluation and Research.
Importation of Electronic Products
CFR Part 1005 establishes importation requirements for electronic products subject to federal radiation control standards. Imported electronic products must bear compliance certification labels or tags; non-complying products are refused entry unless brought into compliance through a petition process. The regulation provides procedures for sample testing, inspection, notification, and hearing rights for importers.
Current Good Manufacturing Practice for Blood and Blood Components
21 CFR Part 606 establishes current good manufacturing practice (cGMP) standards for blood and blood components collection, processing, compatibility testing, storage and distribution. The regulation defines key terms including blood, blood components, plasmapheresis, plateletpheresis, and leukapheresis procedures. It requires facilities and personnel to maintain adequate safety, purity, potency and effectiveness, with personnel having appropriate education, training and experience. Facilities must be clean, orderly, suitably constructed and properly maintained to ensure compliance with cGMP requirements.
Performance Standards for Microwave and Radio Frequency Emitting Products
This regulation establishes performance standards for microwave ovens manufactured after October 6, 1971, setting limits on microwave radiation emission and requiring safety interlocks. Microwave ovens must not exceed 1 milliwatt per square centimeter power density at 5+ centimeters from the external surface before purchase, and 5 milliwatts per square centimeter thereafter. Devices must have at least two operative safety interlocks designed to prevent microwave generation when cavity access is possible, with at least one interlock resistant to human body contact and magnetic manipulation.
Cosmetic Labeling
21 CFR Part 701 establishes labeling requirements for cosmetic products, including prohibitions on misbranding, specifications for ingredient declaration in descending order of predominance, and standards for label prominence and conspicuousness. Requirements address language, visibility, and accurate ingredient representation to prevent consumer deception.
Food Additives
21 CFR Part 570 establishes regulatory definitions and provisions governing food additives under the Federal Food, Drug, and Cosmetic Act. It defines food additives as substances not exempted that become food components or affect food characteristics, including packaging materials with migration potential. The regulation outlines safety standards, requiring reasonable certainty of harmlessness based on scientific procedures, and addresses general recognition of safety, cumulative dietary effects, and prior sanctions.
Exemptions from Federal Preemption of State and Local Medical Device Requirements
21 CFR Part 808 establishes procedures for states and localities to seek exemption from federal preemption of medical device requirements under the Federal Food, Drug, and Cosmetic Act. The FDA Commissioner may grant exemptions for state/local requirements that are either more stringent than federal standards or required by compelling local conditions, provided they do not conflict with federal law. General applicability requirements and those identical to federal standards remain non-preempted.
Clinical Chemistry and Clinical Toxicology Devices
21 CFR Part 862 establishes the FDA classification framework for clinical chemistry and clinical toxicology devices intended for human use. It defines the scope of device regulation, specifies that calibrators used with these devices are classified as Class II regardless of the device's classification due to their critical role in measurement accuracy, and outlines the premarket approval requirements and effective dates for devices classified as Class III.
General
21 CFR Part 800 establishes sterility and tamper-resistant packaging requirements for contact lens solutions and ophthalmic medical devices. All contact lens solutions, eye cups, and similar ophthalmic preparations must be sterile at the time of filling and closing, with appropriate labeling and warnings. Multiple-dose containers must contain preservatives or be labeled with duration limits. Products failing to meet these standards are considered adulterated or misbranded.
Cosmetic Product Warning Statements
21 CFR Part 740 establishes requirements for warning statements on cosmetic product labels. Manufacturers must display warnings whenever necessary to prevent health hazards, with statements appearing prominently in bold type on contrasting backgrounds (minimum 1/16 inch height). Specific warnings are mandated for products with unsubstantiated safety claims and for self-pressurized containers, including precautions against eye contact, puncture, incineration, and high temperature exposure.
Additional Standards for Diagnostic Substances for Laboratory Tests
21 CFR Part 660 establishes additional standards for diagnostic substances used in laboratory tests, specifically covering antibody to hepatitis B surface antigen. The regulation defines proper sourcing from immunized animal plasma/blood or hepatitis B surface antigen-positive human donors, specifies processing methods to ensure specificity and potency, and mandates labeling requirements including source indication, test method recommendations, and hepatitis transmission warnings. Ancillary reagents must meet purity standards and be manufactured to prevent contamination.
Food Additives Permitted in Feed and Drinking Water of Animals
21 CFR Part 573 establishes permitted food additives for animal feed and drinking water. Regulations cover acrylamide-acrylic acid resin as a thickener/suspending agent in aqueous feed suspensions, aminoglycoside 3'-phosphotransferase II enzyme for genetic modification of crops, ammoniated cottonseed meal as a protein source in ruminant feed (max 20% of ration), and ammoniated rice hulls as fiber and nonprotein nitrogen source in beef cattle feed (max 20% of ration). Each additive includes specifications, approved uses, and labeling requirements for safe application.
Performance Standards for Electronic Products: General
Performance standards for electronic products under 21 CFR Part 1010 establish certification and labeling requirements to control electronic product radiation. Manufacturers must certify conformance to applicable standards via permanently affixed labels or tags, with certification based on individual product testing or qualified manufacturing programs. The regulation covers general provisions for radiation control and includes specific provisions for laser products incorporating certified laser systems.
Oral Dosage Form New Animal Drugs
21 CFR Part 520 establishes specifications and conditions of use for oral dosage form new animal drugs, including acepromazine (tranquilizer for dogs and cats), acetazolamide (for heart failure and intraocular pressure in dogs), afoxolaner/moxidectin/pyrantel combination (for heartworm prevention and parasite control in dogs), and albendazole suspension (for livestock). All drugs require veterinary oversight and specify dosage amounts, indications for use, and applicable limitations.
General Biological Products Standards
21 CFR Part 610 establishes general standards for licensed biological products in the US, requiring manufacturers to complete conformity tests on each product lot before release and permitting FDA oversight of lot samples and protocols. The regulation specifies testing requirements for potency, sterility, and safety, allows equivalent methods with FDA approval, and governs release procedures through the Center for Biologics Evaluation and Research or Center for Drug Evaluation and Research.
Medical Device Classification Procedures
21 CFR Part 860 establishes the procedures and criteria for classifying and reclassifying medical devices intended for human use into one of three regulatory control classes (I, II, or III) based on safety and effectiveness. The regulation defines classification criteria, describes the roles of advisory committees and the FDA Commissioner, and prescribes the data required to support device classification determinations. It also governs public participation and information disclosure in classification proceedings.
Regulations Under the Federal Caustic Poison Act
21 CFR Part 1230 establishes labeling and packaging requirements for caustic and corrosive substances shipped in interstate or foreign commerce. Containers must bear clear labels with the common name of the dangerous substance, prominent "Poison" warnings in 24-point Gothic capitals, and directions for medical treatment in case of internal or external injury. Labeling must be firmly affixed and readily visible. Manufacturers, wholesalers, and distributors are responsible for compliance, with limited exemptions for non-household containers at shipment.
Repurchase, Repairs, or Replacement of Electronic Products
CFR Part 1004 establishes manufacturer obligations for electronic products that fail to comply with federal standards or have defects. Manufacturers must repair and bring products into conformity, replace them with equivalent compliant products, or refund the purchase price at no cost to consumers, including reimbursement for transportation. Manufacturers must submit detailed plans to the Secretary for approval before executing repairs or replacements.
Labeling
FDA regulation 21 CFR Part 801 establishes labeling requirements for medical devices in package form. Manufacturers, packers, and distributors must conspicuously display their name and place of business (including street address, city, state, and ZIP code) on device labels. Labels must clarify the relationship between the labeled entity and the device (e.g., "Manufactured for", "Distributed by"). The regulation defines key terms including implantable devices, finished devices, expiration dates, and automatic identification and data capture (AIDC) technology for unique device identification.
Requirements for Electronic Orders and Prescriptions
21 CFR Part 1311 establishes requirements for electronic orders and prescriptions of controlled substances, particularly Schedule I and II drugs. It mandates that electronic transmission systems meet authentication, nonrepudiation, and message integrity standards, with digital signatures using Public Key Infrastructure (PKI) technology identified as compliant. The regulation incorporates by reference cryptographic security standards from NIST, including FIPS publications 140-2, 180-2, and 180-3.
New Animal Drugs for Minor Use and Minor Species
This regulation (21 CFR Part 516) establishes procedures for designating and approving new animal drugs for minor uses and minor species, implementing section 573 of the Federal Food, Drug, and Cosmetic Act. It defines key terms including minor use, minor species, major species, MUMS drugs, and requirements for demonstrating functional superiority. The rule governs various dosage forms including oral, injectable, ophthalmic, topical, and feed-based formulations for animals other than humans or major livestock species.
Substances Generally Recognized as Safe
21 CFR Part 582 establishes the regulatory framework for substances generally recognized as safe (GRAS) for use in food and animal feed. The regulation defines GRAS status, outlines good manufacturing and feeding practices including restrictions on quantities, and authorizes the FDA Commissioner to maintain lists of approved substances such as spices, essential oils, natural seasonings, and flavorings. Substances must be of appropriate grade and prepared as food ingredients, with quantities limited to what is reasonably necessary to accomplish their intended effect.
Performance Standards for Light-Emitting Products
FDA performance standards for laser products manufactured after August 1, 1976, establishing safety classifications (Class I, IIa, II, etc.) and accessible emission limits to protect human exposure to laser radiation. Manufacturers must register products, provide warning labels and safe installation instructions, and maintain distribution records.